This is a preview of subscription content, log in via an institution to check access.
Reference
Roodenrijs NMT, et al. Health care utilisation and economic burden of difficult-to-treat rheumatoid arthritis: a cost-of-illness study. Rheumatology : 27 Jan 2021. Available from: URL: http://doi.org/10.1093/rheumatology/keab078
Rights and permissions
About this article
Cite this article
Difficult-to-treat rheumatoid arthritis high economic burden in the Netherlands. PharmacoEcon Outcomes News 871, 12 (2021). https://doi.org/10.1007/s40274-021-7450-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-021-7450-4